Cargando…
Kras as a key oncogene and therapeutic target in pancreatic cancer
Pancreatic cancer is one of the deadliest human malignancies and little progress has been achieved in its treatment over the past decades. Advances in our understanding of the biology of this disease provide new potential opportunities for treatment. Pancreatic cancer is preceded by precursor lesion...
Autores principales: | Collins, Meredith A., Pasca di Magliano, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896882/ https://www.ncbi.nlm.nih.gov/pubmed/24478710 http://dx.doi.org/10.3389/fphys.2013.00407 |
Ejemplares similares
-
Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
por: Collins, Meredith A., et al.
Publicado: (2012) -
Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models
por: DeCant, Brian T., et al.
Publicado: (2014) -
Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer
por: Du, Wenting, et al.
Publicado: (2021) -
Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in
Pancreatic Cancer
por: Kamerkar, Sushrut, et al.
Publicado: (2017) -
Tyrosine Sulfation: A New Player and Potential Target in Pancreatic Cancer
por: Zhang, Yaqing, et al.
Publicado: (2023)